As the most abundant soluble protein in the body (about 4% in serum) and the most prominent protein in plasma, serum albumin (SA) is responsible for a multiplicity of functions, including the maintenance of blood osmolarity, acting as an antioxidant, and serving as a solubilizer and carrier for many endogenous and exogenous compounds.
1) It is also a major binding protein for the transport of a large number of drugs, their metabolites, and endogenous ligands. 1) Binding of a drug to HSA controls its free, active concentration, which provides a reservoir of the drug for a sustained action. In addition, studies of SA have also revealed the important role of this protein as a catalyst for the hydrolysis of various compounds, such as esters, amides and phosphates. 2, 3) Human and bovine serum albumin (HSA and BSA, respectively) are known to have at least two distinct ligandbinding sites, namely Sudlow's Site I, also called the warfarin binding site, and Site II, also called the indole and benzodiazepine binding site. 1) Studies of HSA also demonstrated that esterase-like sites are located in the drug binding sites I and II. 3, 4) Amino acid residues of lysine (Lys) and tryptophan (Trp) on site I and tyrosine (Tyr) and arginine (Arg) on site II are related to both the ligand binding properties and the esterase-like activity of SA. 4, 5) Furthermore, Trp is reported to play an important role in the oxidative stress of HSA. 6) In previous studies, several direct chemical modifications, such as galactosylation, mannosylation, succinylation and cationization, have been used to modify BSA to develop targetable drug delivery systems via receptor or charge-mediated mechanisms, and all of these modified BSA derivatives showed rapid elimination from the systemic circulation as well as increased and rapid hepatic uptake after intravenous injection into mice. [7] [8] [9] [10] These chemically modified BSA derivatives can be used in active drug targeting, where drugs conjugated to a carrier molecule are selectively and rapidly delivered to target cells. However, such rapid uptake of chemically modified BSA derivatives may be unfavorable when sustained drug delivery is required.
Although charged amino acid residues are more easily modified than non-charged ones, the changes in the net charge of BSA greatly alter its tissue distribution. 9, 10) Therefore, to obtain SA-drug conjugates that exhibit sustained circulation, it is important to select suitable residues on SA for chemical conjugation. In the present study, therefore, to investigate the effect of functional groups of BSA on its tissue distribution characteristics, Tyr and Trp residues of BSA were selectively modified using tetranitromethane (TNM) and 2-hydroxy-5-nitrobenzyl bromide (HNB), respectively. BSA derivatives (TNM-BSA and HNB-BSA) with different degrees of modification were synthesized, and then the structural properties and tissue distribution characteristics of these BSA derivatives were examined. To investigate the effect of functional groups in bovine serum albumin (BSA) on its tissue distribution characteristics, tyrosine (Tyr) or tryptophan (Trp) residues of BSA were chemically modified by tetranitromethane (TNM) and 2-hydroxy-5-nitrobenzyl bromide (HNB), respectively. BSA was successfully modified with each reagent depending on the amount of the reagent added to the reaction mixture, and TNM-and HNB-modified BSA derivatives with different degrees of modification were obtained. Circular dichroism measurements showed that slight secondary and large tertiary changes were detectable as the degree of modification increased. After intravenous injection into mice, all synthetic BSA derivatives were eliminated very slowly from the systemic circulation. However,
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In-TNM 6.6 -and
In-HNB 2.0 -BSA, derivatives with a high degree of modification, showed a slightly faster disappearance from the systemic circulation and slightly higher accumulation in the liver than
In-unmodified BSA. Pharmacokinetic analyses also demonstrated that the modification of Tyr or Trp residues on BSA had only marginal effects on tissue distribution. These results indicate that the Tyr and Trp residues have little effect on the tissue distribution characteristics of serum albumins, and that the specific modification of these residues may be a promising approach to designing sustained drug delivery systems using serum albumins.
ments were conducted in accordance with the principles and procedures outlined in the National Institute of Health Guide for the Care and Use of Laboratory Animals. The protocols for animal experiments were approved by the Animal Experimentation Committee of Graduate School of Pharmaceutical Sciences of Kyoto University.
Synthesis of TNM-and HNB-BSA Derivatives TNM-BSA (Tyr-Modified BSA): The modification of Tyr residues of BSA was carried out according to the method of Sokolovsky et al. 12) In brief, aliquots of a 0.084 M solution of TNM in 100% ethanol were added to 1% BSA solution (0.05 M Tris buffer, pH 8.0). The reaction mixture was incubated for 2 h at room temperature, and then freeze-dried after dialysis against water.
The modification ratio was calculated by the equation below:
Where DA 428 nm is the difference in the absorbance at 428 nm between BSA and TNM-BSA; C is the protein concentration; m is the moles of Tyr per mole of protein (19 for BSA). The absorbance was measured by UV using a UV-1600 Spectrophotometer (Shimadzu Co., Kyoto, Japan).
HNB-BSA (Trp-Modified BSA): The modification of Trp residues was performed according to the method of Fehske et al. 13) In brief, 1 g BSA was dissolved in 200 ml 10 M urea solution and the pH was adjusted to 4.4 by adding acetic acid. To this solution was added TNB in 25 ml methanol and the reaction mixture was shaken occasionally. After 2 h the insoluble hydrolyzed products were separated by centrifugation. The supernatant was dialyzed against water for 60 h, and then lyophilized.
Where A 410 nm and A 280 nm are the absorbances of HNB-BSA at 410 nm and 280 nm, respectively. E 0.1% 280 nm, is the absorption coefficient of 0.1% modified BSA at 280 nm. The absorbance was measured by UV using a UV-1600 Spectrophotometer (Shimadzu Co., Kyoto, Japan).
Circular Dichroism (CD) Measurements CD spectra were recorded using a JASCO-820 type spectropolarimeter (JASCO, Tokyo, Japan) at 25°C. For calculation of the mean residue ellipticity [q], the molecular mass of the BSA derivatives was assumed to be 67 kDa. Far-UV (wave length 200-250 nm) and near-UV (wave length 250-350 nm) CD spectra were recorded at protein concentrations of 5 mM and 15 mM, respectively, in 67 mM sodium phosphate buffer (pH 7.4).
14)
Radiolabeling of TNM-and HNB-BSA Derivatives and Tissue Distribution Experiments BSA derivatives were radiolabeled with 111 In using the bifunctional chelating regent DTPA anhydride according to the method of Hnatowich et al. 15) which has been described previously. 9, 10) Mice received a tail vein injection of 111 In-TNM-or HNB-BSA at a dose of 1 mg/kg in saline and were housed in metabolic cages to allow the collection of urine samples. At appropriate intervals after injection, blood was collected from the vena cava under ether anesthesia and plasma was obtained by centrifugation. The liver, kidney, spleen, lung, heart, and muscle were excised, rinsed with saline and weighed. The radioactivity of each sample was measured in a well-type NaI scintillation counter (ARC-500, Aloka, Tokyo). Radioactivity originating from the plasma in each tissue sample was corrected using the distribution data of 111 In-BSA at 10 min after intravenous injection, assuming that 111
In-BSA was not taken up by tissues during this 10 min period.
Pharmacokinetic Analysis The plasma 111
In radioactivity concentrations were normalized with respect to the percentage of the dose per milliliter and analyzed using the nonlinear least-square program MULTI.
16) The tissue distribution was evaluated using the liver and kidney uptake clearance (CL liver and CL kidney ) as described previously. 
RESULTS
Physicochemical Properties of TNM-and HNB-BSA
Derivatives Synthesis of TNM-and HNB-BSA Derivatives: The Tyr and Trp residues of BSA were chemically modified with TNM and HNB, respectively. BSA was successfully modified with each reagent, and the numbers of the residues modified increased with the increasing amount of reagent added to the reaction mixture. Table 1 summarizes the amount of the reagents added and the degree of modification. The numbers of Tyr residues modified were 1.7, 4.5 and 6.6 for TNM-BSA derivatives, and those of Trp residues modified were 1.5 and 2.0 for HNB-BSA derivatives.
Structural Properties of TNM-and HNB-BSA Derivatives: Figure 1 shows the far-UV and near-UV CD spectra of TNM-and HNB-BSA derivatives. In the far-UV region, the spectra of TNM 1.7 -BSA, TNM 4.5 -BSA and TNM 6.6 -BSA were almost identical to that of BSA (Fig. 1A) . In the case of HNB 1.5 -BSA and HNB 2.0 -BSA, the q obs values were higher than BSA, indicating some loss of the a-helix structure (Fig.  1B) . In the near-UV region, all TNM-and HNB-BSA derivatives showed some changes in the tertiary structure, especially those extensively modified (Figs. 1C, D) .
Tissue Distribution and Pharmacokinetic Analysis of In-HNB-BSA Derivatives after Intravenous Injection in Mice: Figure 2 shows the timecourses of the plasma concentration, tissue accumulation and urinary excretion of radioactivity after intravenous injection of 111 In-BSA ( Fig. 2A) 111
In-TNM 6.6 -BSA (Fig. 2B ) and The number of residues modified was measured as described in Materials and Methods. The number in parentheses for BSA is the number of residues before modification. In-HNB 2.0 -BSA (Fig. 2C) . Contrary to the lysine-modified BSA derivatives, both In-HNB 2.0 -BSA. Calculation of AUC and Tissue Uptake Clearance: The liver (CL liver ) and kidney (CL kidney ) clearances and the AUC were calculated based on the tissue distribution data ( Table  2 ). The AUC values were reduced following any modification. Both the CL liver and CL kidney values increased following modification, with a greater change in the CL liver .
DISCUSSION
Amino acid residues, such as Lys, Tyr, Trp and Arg, are very important for the functional properties of SA.
1) Lys-199 and Trp-214 on site I and Tyr-411 and Arg-410 on site II are generally assumed to be important for ligand-binding and the enzymatic properties of HSA. 4, 5, 17) In addition, the single Trp residue of HSA, Trp-214, located in the hydrophobic part of the binding pocket in subdomain IIA, is also important for holding together the two halves of the heart-shaped albumin, 18, 19) and is affected in the oxidative stress of HSA.
6) The sequences of HSA and BSA exhibit striking homology. 20) Therefore, two Trp residues, located in positions 134 and 212, and 19 Tyr residues of BSA are considerable to play an important role in the functional properties of BSA.
Although some applications of SA have been evaluated thoroughly to develop targeted and sustained drug delivery systems through chemical modification and microsphere formulation technologies, [7] [8] [9] [10] [21] [22] [23] [24] [25] [26] little attention has been paid to the effect of functional groups of SA on the development of site-specific delivery of proteins. Furthermore, the conformational changes in BSA occur in the vicinity of the Trp and Tyr residues during chemical modification, 10, 27) suggesting a relationship between the Trp and Tyr residues of BSA and its tissue distribution characteristics. Therefore, in the present study, the role of Trp and Tyr residues on the tissue distribution characteristics of BSA was investigated by chemical modification.
TNM and HNB, the two modifier reagents, were reported to selectively modify Tyr and Trp residues, respectively. 12, 13, 28) Increasing the amounts of TNM and HNB produced a significant increase in the degree of modification and some changes occurred in the secondary and tertiary structures of the modified BSA derivatives. The changes in the far-UV region indicated that the modification of Tyr and Trp residues of BSA had a minor effect on the secondary structure of BSA, although little loss of the a-helix was observed in the HNB-BSA derivatives. In contrast, the near-UV CD spectra were markedly changed following modification with TNM or HNB, and the changes became greater as the degree of modification increased. Because the near-UV spectra indicate the tertiary structural changes in the environment of the disulfide bonds and aromatic amino acid residues, 27) these results are in good agreement with the fact that aromatic Tyr residues or Trp residues of BSA are selectively modified by TNM or HNB, respectively.
The chemical modification of Tyr and Trp slightly increased the hepatic uptake in parallel with a reduction in plasma concentration. Even after extensive modification, the changes in the AUC and tissue uptake clearances were not very significant. In previous studies, the BSA derivatives modified at Lys residues with galactose, mannose, or succinic anhydride, or at carboxyl groups with ethylenediamine or hexamethylenediamine showed marked changes in tissue distribution; the CL liver of values of these BSA derivatives exceed 20000 ml/h at the same dose as one used in this study (1 mg/kg). [7] [8] [9] [10] The tissue distribution characteristics of TNM-and HNB-BSA derivatives indicate a potential application of Tyr-or Trp-modified BSA derivatives in the development of sustained drug delivery systems.
In conclusion, the present study has investigated the structural properties and pharmacokinetic characteristics of Tyrand Trp-modified BSA derivatives, two functionally important amino acid residues in SA. The tissue distribution data suggest that the Tyr and Trp residues are not important in determining the tissue distribution of BSA, suggesting their potential use in sustained delivery systems involving little change in structure. 
